ArticleTargeted oncology2016
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Anne von Mässenhausen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleTargeted oncology2016
Anne von Mässenhausen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.